• Commentary
  • Published April 2019

Evidence and efficacy: time to think beyond the traditional randomised controlled trial in patient safety studies.

The design of research in patient safety has garnered controversy. This commentary suggests that approaches beyond the randomized controlled trial are needed to spur the rapid development of evidence needed to drive progress.

Back to Top